Lauren Murdza is a corporate attorney who advises life sciences, healthcare, biotech, medical device and technology companies and universities, in connection with technology transactions and general corporate matters. She represents clients in a broad range of commercial and corporate activities, including early-stage licensing and development agreements, global collaboration and promotional agreements, product acquisitions and divestitures, merger and acquisitions and private company financings.
Lauren's clients range from emerging growth companies to Fortune 500 companies in the US and Europe, specifically in the life sciences and technology sectors.
In addition, Lauren advises clients on day-to-day commercial agreements, such as research and development agreements, clinical trial agreements, joint development agreements, licenses, manufacturing and distribution agreements, promotional agreements, joint ventures and corporate partnering arrangements. She has a depth of experience in commercial contracts and management of large commercial contract portfolios for global clients.
- J.D., Villanova University School of Law
- B.S., Loyola University Maryland
- Financial Times Most Innovative Practitioner short list nomination (2022)
- Legal Intelligencer Unsung Hero Award (2021)
- The Legal 500 United States
Recommended, Intellectual Property Patents: Licensing (2021)
Recommended, Venture Capital & Emerging Companies (2016)
Prior to joining DLA Piper, Lauren was a corporate attorney at a large international law firm. She began her legal career as an associate at an intellectual property boutique representing clients in the life sciences and technology sectors in connection with their intellectual property needs. During law school, Lauren worked at a clinical research services organization. Before attending law school, Lauren interned in the legal department of a pharmaceutical company.
Memberships And Affiliations
- Benjamin Franklin American Inn of Court (Immediate Past President)
My latest insights
DLA Piper advises BASF on global carve-out of mobile emissions catalysts and precious...
18 September 2023 .5 minute read
DLA Piper announces new leadership of its US Technology and Life Sciences Transaction and...
7 August 2023 .2 minute read